Trade Mark Journal No.2025/041 10 October 2025
WO0000001877039 (5)
Office of origin: United States of America
Date of International Registration:19 August 2025
Date of designation in the UK:
19 August 2025

International priority date claimed: 26 February 2025
(United States of America)
(99057610)
- Class 5
- Radiopharmaceutical imaging and detection agents for detection, diagnosing and monitoring cancer; pharmaceutical preparations for the detection, diagnosis and monitoring of cancer.
Progenics Pharmaceuticals, Inc.
Representative: Douglas R. Wolf Wolf Greenfield & Sacks, P.C., 600 Atlantic Avenue, Boston MA 02210, UNITED STATES OF AMERICA